Fiduciary Trust CO Rhythm Pharmaceuticals, Inc. Transaction History
Fiduciary Trust CO
- $7.39 Billion
- Q1 2025
A detailed history of Fiduciary Trust CO transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 15,000 shares of RYTM stock, worth $1.28 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,000
Previous 20,000
25.0%
Holding current value
$1.28 Million
Previous $1.12 Million
28.98%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding RYTM
# of Institutions
248Shares Held
63MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$577 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$521 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$496 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$480 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$295 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $4.77B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...